Which factors influence the quality of end-of-life care in interstitial lung disease? A systematic review with narrative synthesis

1. Travis, WD, Costabel, U, Hansell, DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733–748.
Google Scholar | Crossref | Medline | ISI2. BLF . What is pulmonary fibrosis?, https://www.blf.org.uk/support-for-you/pulmonary-fibrosis/what-is-pulmonary-fibrsis (2019, accessed 17 August 2020).
Google Scholar3. Carvajalino, S, Reigada, C, Johnson, MJ, et al. Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review. BMC Pulm Med 2018; 18(1): 78.
Google Scholar | Crossref | Medline4. Wuyts, WA, Papiris, S, Manali, E, et al. The burden of progressive fibrosing interstitial lung disease: a DELPHI approach. Adv Ther 2020; 37: 3246–3264.
Google Scholar | Crossref | Medline5. NICE NIfHaCE . Idiopathic pulmonary fibrosis in adults: diagnosis and management, https://www.nice.org.uk/guidance/cg163/chapter/Introduction (2017, accessed 6 August 2020).
Google Scholar6. Bourke, SJ, Peel, ET. Palliative care of chronic progressive lung disease. Clin Med (Lond) 2014; 14: 79–82.
Google Scholar | Crossref | Medline7. Song, JW, Hong, S-B, Lim, C-M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 2011; 37: 356–363.
Google Scholar | Crossref | Medline | ISI8. Bajwah, S, Oluyase, AO, Yi, D, et al. The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers. Cochrane Database Syst Rev 2020; 9: Cd012780.
Google Scholar | Medline9. Bylicki, O, Didier, M, Riviere, F, et al. Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care. BMJ Support Palliat Care 2019; 9: 413–424.
Google Scholar | Medline10. Butler, SJ, Ellerton, L, Gershon, AS, et al. Comparison of end-of-life care in people with chronic obstructive pulmonary disease or lung cancer: a systematic review. Palliat Med 2020; 34: 1030–1043.
Google Scholar | SAGE Journals | ISI11. Ley, B, Collard, HR, King, TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 183: 431–440.
Google Scholar | Crossref | Medline | ISI12. Popay, J, Roberts, H, Sowden, A, et al. Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme, 2006. https://www.lancaster.ac.uk/media/lancaster-university/content-assets/documents/fhm/dhr/chir/NSsynthesisguidanceVersion1-April2006.pdf (accessed 26 February 2021).
Google Scholar13. Page, MJ, McKenzie, JE, Bossuyt, PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.
Google Scholar | Crossref | Medline14. General Medical Council . Treatment and care towards the end of life: good practice in decision making. https://www.gmc-uk.org/ethical-guidance/ethical-guidance-for-doctors/treatment-and-care-towards-the-end-of-life (2020, accessed 5 March 2020).
Google Scholar15. Rajala, K, Lehto, JT, Saarinen, M, et al. End-of-life care of patients with idiopathic pulmonary fibrosis. BMC Palliat Care 2016; 15: 1–6.
Google Scholar | Crossref | Medline16. Guo, H, Mann, J, Goh, N, et al. Investigation burden for patients with fibrotic interstitial lung disease at the end of life. Intern Med J 2020; 50: 748–752.
Google Scholar | Crossref | Medline17. Rush, B, Berger, L, Anthony Celi, L. Access to palliative care for patients undergoing mechanical ventilation with idiopathic pulmonary fibrosis in the United States. Am J Hosp Palliat Med 2018; 35: 492–496.
Google Scholar | SAGE Journals | ISI18. Liang, Z, Hoffman, LA, Nouraie, M, et al. Referral to palliative care infrequent in patients with idiopathic pulmonary fibrosis admitted to an intensive care unit. J Palliat Med 2017; 20: 134–140.
Google Scholar | Crossref | Medline19. Brown, CE, Engelberg, RA, Nielsen, EL, et al. Palliative care for patients dying in the intensive care unit with chronic lung disease compared with metastatic cancer. Ann Am Thorac Soc 2016; 13: 684–689.
Google Scholar | Crossref | Medline20. Kalluri, M, Claveria, F, Ainsley, E, et al. Beyond idiopathic pulmonary fibrosis diagnosis: multidisciplinary care with an early integrated palliative approach is associated with a decrease in acute care utilization and hospital deaths. J Pain Symptom Manage 2018; 55: 420–426.
Google Scholar | Crossref | Medline21. Kalluri, M, Lu-Song, J, Younus, S, et al. Health care costs at the end of life for patients with idiopathic pulmonary fibrosis. Evaluation of a pilot multidisciplinary collaborative interstitial lung disease clinic. Ann Am Thorac Soc 2020; 17: 706–713.
Google Scholar | Crossref | Medline22. Lindell, KO, Liang, Z, Hoffman, LA, et al. Palliative care and location of death in decedents with idiopathic pulmonary fibrosis. Chest 2015; 147: 423–429.
Google Scholar | Crossref | Medline | ISI23. Ahmadi, Z, Wysham, NG, Lundstrom, S, et al. End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study. Thorax 2016; 71: 510–516.
Google Scholar | Crossref | Medline | ISI24. Bajwah, S, Higginson, IJ, Ross, JR, et al. Specialist palliative care is more than drugs: a retrospective study of ILD Patients. Lung 2012; 190: 215–220.
Google Scholar | Crossref | Medline | ISI25. Zou, RH, Nouraie, M, Chen, X, et al. Assessing patterns of palliative care referral and location of death in patients with idiopathic pulmonary fibrosis: a sixteen-year single-center retrospective cohort study. J Palliat Med 2019; 22: 538–544.
Google Scholar | Crossref | Medline26. Smallwood, N, Mann, J, Guo, H, et al. Patients with fibrotic interstitial lung disease receive supportive and palliative care just prior to death. Am J Hosp Palliat Med 2021; 38: 154–160.
Google Scholar | SAGE Journals | ISI27. Archibald, N, Bakal, JA, Richman-Eisenstat, J, et al. Early integrated palliative care bundle impacts location of death in interstitial lung disease: a pilot retrospective study. Am J Hosp Palliat Med 2021; 38(2): 104–113.
Google Scholar | SAGE Journals | ISI28. Koyauchi, T, Suzuki, Y, Sato, K, et al. Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study. Thorax 2021; 76: 248–255.
Google Scholar | Crossref | Medline29. Kim, JW, Olive, S, Jones, S, et al. Interstitial lung disease and specialist palliative care access: a healthcare professionals survey. BMJ Support Palliat Care. Epub ahead of print 18 June 2020. DOI: 10.1136/bmjspcare-2019-002148.
Google Scholar | Crossref30. Akiyama, N, Fujisawa, T, Morita, T, et al. Palliative care for idiopathic pulmonary fibrosis patients: pulmonary physicians’ view. J Pain Symptom Manage 2020; 60(5): 933–940.
Google Scholar | Crossref | Medline31. Barril, S, Alonso, A, Rodriguez-Portal, JA, et al. Palliative care in diffuse interstitial lung disease: results of a Spanish survey. Arch Bronconeumol 2018; 54: 123–127.
Google Scholar | Crossref | Medline32. Bajwah, S, Ross, JR, Wells, AU, et al. Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention. Thorax 2015; 70(9): 830–839.
Google Scholar | Crossref | Medline33. Barratt, SL, Morales, M, Spiers, T, et al. Specialist palliative care, psychology, interstitial lung disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs. BMJ Open Respir Res 2018; 5: 1–5.
Google Scholar34. Rajala, K, Lehto, JT, Sutinen, E, et al. Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life. BMC Pulm Med 2018; 18: 1–9.
Google Scholar | Crossref | Medline35. Janssen, K, Rosielle, D, Wang, Q, et al. The impact of palliative care on quality of life, anxiety, and depression in idiopathic pulmonary fibrosis: a randomized controlled pilot study. Respir Res 2020; 21: 2.
Google Scholar | Crossref | Medline36. Lindell, KO, Olshansky, E, Song, MK, et al. Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners. Heart Lung 2010; 39: 304–313.
Google Scholar | Crossref | Medline | ISI37. Higginson, IJ, Reilly, CC, Bajwah, S, et al. Which patients with advanced respiratory disease die in hospital? A 14-year population-based study of trends and associated factors. BMC Med 2017; 15: 1–12.
Google Scholar | Crossref | Medline38. Cross, SH, Ely, EW, Kavalieratos, D, et al. Place of death for individuals with chronic lung disease: trends and associated factors from 2003 to 2017 in the United States. Chest 2020; 158(2): 670–680.
Google Scholar | Crossref | Medline39. Kavanagh, E, Palmer, E, Donaldson, C, et al. P-91 integration of specialist palliative care into a tertiary non-malignant service: evaluation of potential geographical disparity. BMJ Support Palliat Care 2017; 7: A33–A34.
Google Scholar | Crossref40. Wakefield, K, Palmer, E, Donaldson, C, et al. 49 Review of potential geographical disparities in access to anti-fibrotic medication and clinic-based specialist palliative care for patients with idiopathic pulmonary fibrosis. BMJ Support Palliat Care 2019; 9: A19–A19.
Google Scholar41. Mc Veigh, C, Reid, J, Larkin, P, et al. The experience of palliative care service provision for people with non-malignant respiratory disease and their family carers: an all-Ireland qualitative study. J Adv Nurs 2018; 74: 383–394.
Google Scholar | Crossref | Medline42. Jabbarian, LJ, Zwakman, M, Van Der Heide, A, et al. Advance care planning for patients with chronic respiratory diseases: a systematic review of preferences and practices. Thorax 2018; 73: 222–230.
Google Scholar | Crossref | Medline43. Sinclair, C, Auret, KA, Evans, SF, et al. Impact of a nurse-led advance care planning intervention on satisfaction, health-related quality of life, and health care utilization among patients with severe respiratory disease: a randomized patient-preference trial. J Pain Symptom Manage 2020; 59: 848–855.
Google Scholar | Crossref | Medline44. Hjorth, NE, Schaufel, MA, Sigurdardottir, KR, et al. Feasibility and acceptability of introducing advance care planning on a thoracic medicine inpatient ward: an exploratory mixed method study. BMJ Open Respir Res 2020; 7: 1–10.
Google Scholar45. Hjorth, NE, Haugen, DF, Schaufel, MA. Advance care planning in life-threatening pulmonary disease: a focus group study. ERJ Open Res 2018; 4: 1–9.
Google Scholar | Crossref46. Smallwood, N, Thompson, M, Warrender-Sparkes, M, et al. Integrated respiratory and palliative care may improve outcomes in advanced lung disease. ERJ Open Res 2018; 4: 1–9.
Google Scholar | Crossref47. Higginson, IJ, Bausewein, C, Reilly, CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2014; 2: 979–987.
Google Scholar | Crossref | Medline48. Brighton, LJ, Miller, S, Farquhar, M, et al. Holistic services for people with advanced disease and chronic breathlessness: a systematic review and meta-analysis. Thorax 2019; 74: 270–281.
Google Scholar | Crossref | Medline49. Murtagh, FE, Ramsenthaler, C, Firth, A, et al. A brief, patient- and proxy-reported outcome measure in advanced illness: validity, reliability and responsiveness of the Integrated Palliative Care Outcome Scale (IPOS). Palliat Med 2019; 33: 1045–1057.
Google Scholar | SAGE Journals | ISI50. Sharp, C, Lamb, H, Jordan, N, et al. Development of tools to facilitate palliative and supportive care referral for patients with idiopathic pulmonary fibrosis. BMJ Support Palliat Care 2018; 8: 340–346.

留言 (0)

沒有登入
gif